Appointment of Chief Financial Officer
Faron Pharmaceuticals Ltd. (“Faron” or the “Company”) Appointment of Chief Financial Officer Company announcement, 8 August 2024 at 2:00 a.m. EDT / 7:00 a.m. BST / 9:00 a.m. EEST TURKU, FINLAND / BOSTON, MA - Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company pursuing a CLEVER approach to reprogramming myeloid cells to activate anti-tumor immunity in hematological and solid tumor microenvironments, today announces the appointment of Yrjö Wichmann, Faron’s current interim Chief Financial Officer (CFO,